One in 10 adults were at risk of overdose, with older Americans relying on high doses of opioids more than younger adults, researchers found in a national sample of prescription claims. Contact: Emily Gersema at firstname.lastname@example.org or (213) 712-3168 or Michele Keller at email@example.com or (213) 210-6072 Even with COVID-19 dominating the news, the epidemic of opioid use remains […]
Keck Medicine of USC
• Biofluid Dynamics • Fluid-Structure Interaction • Cardiovascular MRI • Hemodynamics • Cardiovascular Devices • Bio-inspired Design • Physics of Fluids in Cardiovascular and Cerebrovascular Diseases • Heart Failure • Myocardial Infarction (Heart Attack) • Aortic Diseases
Expert in predictors of health behaviors among ethnically diverse adolescents and young adults.
Expert in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB, COVID-19 and cryptococcal infections.
Expert in Retinal Diseases, Retinopathy of Prematurity (ROP), Pediatric Ophthalmology
Expert on biomedical engineering, engineered cardiac tissues, heart disease, cardiac development, engineered skeletal muscle, stem cell biology and regenerative medicine, developmental biology, tissue engineering, biomaterials, microfabrication, 3D printing, fluidic devices, disease modeling, organs on chips.
Eye trauma Thyroid eye disease Plastic surgery of the eyelids and face Blindness from filler complications Botox and aeshtic treatments Droopy eyelids Tear duct problems Eyelid cancer Eyelid tumors Styes Eyelid infections Eye infections Dry eyes New technology for dry eye treatment
Pediatric retina Gene therapy Retinopathy of prematurity Leber congenital amaurosis Luxturna
Expert in stem cell biology and regenerative medicine; orthopaedic surgery; arthritis; joint cartilage; skeletal regeneration; fibrotic disorders; chronic inflammation.
Expert on stem cell biology and regenerative medicine; developmental biology; ALS; Alzheimer’s disease; Frontotemporal Dementia; neurodegenerative diseases; induced pluripotent stem cells; cell reprogramming; disease modeling